SARS-CoV-2 - Spike ELISA IgG |
IMS2907 |
ImmunoStep |
1 |
EUR 572 |
Description: SARS-CoV-2 - Spike ELISA IgG |
Human IgG antibody Laboratories manufactures the sars-cov protein spike reagents distributed by Genprice. The Sars-Cov Protein Spike reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Sars-Cov products are available in stock. Specificity: Sars-Cov Category: Protein Group: Spike
SARS-CoV Spike Antibody |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike RBD) |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection. |
Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike Trimer) |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection. |
Spike information
SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein |
10-100 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein |
10-117 |
ProSci |
0.1 mg |
EUR 752.1 |
Description: SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein |
SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein |
10-204 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein |
10-206 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein |
10-303 |
ProSci |
0.1 mg |
EUR 632.4 |
Description: SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein |
SARS-CoV-2 (COVID-19) Spike-RBD Recombinant Protein |
10-008 |
ProSci |
0.1 mg |
EUR 714.3 |
Description: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 spike protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on the target cells. SARS-CoV-2 spike protein (RBD) has the potential value for the diagnosis of the virus. |
SARS-CoV-2 (COVID-19) Spike-RBD Recombinant Protein |
10-015 |
ProSci |
0.1 mg |
EUR 714.3 |
Description: SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS CoV-2 spike protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on the target cells. SARS-CoV-2 spike protein (RBD) has the potential value for the diagnosis of the virus. |
Sars-Cov, Spike (N-Term) Recom Protein |
abx060657-1mg |
Abbexa |
1 mg |
EUR 2247.6 |
|
Recombinant SARS-CoV-2 Spike S1 Protein |
RP01261 |
Abclonal |
100μg |
EUR 1397.5 |
|
Recombinant SARS-CoV-2 Spike S1 Protein |
RP01262 |
Abclonal |
100μg |
EUR 682.5 |
|
Recombinant SARS-CoV-2 Spike S1 Protein |
RP01279 |
Abclonal |
1mg |
EUR 201.5 |
|
Recombinant SARS-CoV-2 Spike S1 Protein |
RP01280 |
Abclonal |
1mg |
EUR 201.5 |
|
Recombinant SARS-COV-2 Spike S1 Protein |
RP02333 |
Abclonal |
1000μg |
EUR 243.75 |
|
Recombinant SARS-COV-2 Spike RBD Protein |
RP02325 |
Abclonal |
500μg |
EUR 266.5 |
|
Recombinant SARS-COV-2 Spike RBD Protein |
RP02332 |
Abclonal |
500μg |
EUR 243.75 |
|
SARS-CoV-2 spike glycoprotein S1 protein |
30-2008 |
Fitzgerald |
500 ug |
EUR 680 |
|
Description: SARS-CoV-2 coronavirus spike glycoprotein S1 protein |
SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] |
BSV-COV-AB-01 |
BioServUK |
25 ul |
Ask for price |
Description: SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] (Spike (S2), Monoclonal) |